Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
γδ T Cell Immunotherapy for Hepatocellular Liver Cancer
NCT02425735Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Apr 2015
- Primary completion
- Jun 2016
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of gamma-delta T cells in hepatocellular carcinoma (HCC), sponsored by Fuda Cancer Hospital. Started Apr 2015; status: completed.
02
Drugs
gamma-delta T cells
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02425735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02425735.